Remove Bradbury Remove Invest Remove Product
article thumbnail

Alume Biosciences Gets $5.5M

socalTECH

in a Series A funding round, to go towards its products. According to Alume, the funding came from angel investors, including co-founder Chrysa Mineo (formerly of Receptos and Neurocrine Biosciences) and Dan Bradbury (co-founder and Executive Chairman of Equillium, Inc. and former CEO of Amylin).

Bradbury 113